Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GeneTether Therapeutics Inc C.GTTX

Healthcare
GeneTether Therapeutics Inc. is a Canada-based genetic medicines company focused on creating gene editing therapies based on its proprietary GeneTether platform. The Company's platform technology uses a proprietary method to tether donor deoxyribonucleic acid (DNA) templates to the genome editing complex, making the template readily available for use during the genome editing repair stage. By... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:GTTX)

GeneTether Therapeutics Inc. Announces Third Quarter 2024 Financial Results

TheNewsWire 1 day ago

GeneTether Therapeutics Announces Binding Term Sheet for Private Placement of Units and Exclusive License Agreement of Soft Tissue Sarcoma Drug Candidate

TheNewsWire October 11, 2024

GeneTether Therapeutics Inc. Announces Second Quarter 2024 Financial Results

TheNewsWire August 23, 2024

GeneTether Therapeutics Inc. Announces First Quarter 2024 Financial Results

TheNewsWire May 29, 2024

GeneTether Therapeutics Inc. Announces Fiscal Year 2023 Financial Results and Reports on Corporate Highlights

TheNewsWire March 28, 2024

GeneTether Therapeutics Inc. Announces Third Quarter 2023 Financial Results

TheNewsWire November 28, 2023

GeneTether Therapeutics Board Provides Shareholder Update

TheNewsWire October 20, 2023

GeneTether Therapeutics Inc. Announces Second Quarter 2023 Financial Results

TheNewsWire August 25, 2023

GeneTether Therapeutics Inc. Announces First Quarter 2023 Financial Results and Provides Corporate Update

TheNewsWire May 25, 2023
View More News ››

Opinion & Analysis (CSE:GTTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:GTTX)

RE:300% share price increase

look at 16th October news release
CashFlowReality - 2 days ago

300% share price increase

Anyone know what's driving the share price right now? 
ElBorto - 3 days ago

RE:Look for the share price to start rising...

Time to buy!
CashFlowReality - October 31, 2024

Look for the share price to start rising...

GeneTether Therapeutics Announces Binding Term Sheet for Private Placement of Units and Exclusive License Agreement of Soft Tissue...
CashFlowReality - October 16, 2024

looking for more details on what the other possibilities are

NRs welcome (too)! e.g., is something brewing (or not)?
CashFlowReality - August 27, 2024

Yeap ... people are buying at 0.05

This might pop positive soon... just speculating here (but I do see valuations in the 0.05 range).
CashFlowReality - March 12, 2024
View more Bullboard ››

Majestic Gold Corp.

Majestic Gold Corp.

Majestic Gold Corp. is engaged in mineral resource exploration, development and extraction. It operates the Songjiagou open ...
View More »